The FDA and Aduhelm: WTF?
World of DTC Marketing
JUNE 23, 2021
Not to mention the $56,000 annual price tag. Aduhelm joins a group of drugs that potentially leave patients worse off and much poorer for it. Recall that with this drug, about 30–40 percent of study participants experienced either brain swelling or bleeding.
218 
Let's personalize your content